Systemic Delivery of Nanoformulations of Anti-cancer Drugs with Therapeutic Potency in Animal Models of Cancer

E-ISSN： 1875-6301|12|3|204-220

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.12, Iss.3, 2017-02, pp. : 204-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancement of Intracellular Delivery of Anti-cancer Drugs by the Tat Peptide

By Zhao Jin-Feng Chen Ji-Yao Mi Lan Wang Pei-Nan Peng Qian

Ultrastructural Pathology, Vol. 35, Iss. 3, 2011-05 ,pp. : 119-123

Informa Healthcare

Access to resources Recommend Favorite

Prescribing anti-cancer drugs in elderly cancer patients

By Monfardini S.

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2341-2346

Elsevier

Access to resources Recommend Favorite

The Role of FDA in the Regulation of Anti-Cancer Drugs

Current Cancer Therapy Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 327-329

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Helicases as Targets for Anti-Cancer Drugs

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 3, 2005-05 ,pp. : 183-199

Bentham Science Publishers

Access to resources Recommend Favorite

Mesenchymal Stem Cells for Anti-Cancer Drug Delivery

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 310-318

Bentham Science Publishers

Access to resources Recommend Favorite